FGP
EHC icon

Freestone Grove Partners’s Encompass Health EHC Stock Holding History

Freestone Grove Partners’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23M Buy
237,626
+226,130
+1,967% +$23.2M 0.16% 195
2025
Q4 		$1.22M Sell
11,496
-350,706
-97% -$40.6M 0.01% 445
2025
Q3 		$46M Buy
362,202
+359,763
+14,750% +$42.8M 0.34% 99
2025
Q2 		$299K Sell
2,439
-289,191
-99% -$33M ﹤0.01% 586
2025
Q1 		$29.5M Buy
291,630
+79,695
+38% +$7.78M 0.3% 122
2024
Q4 		$19.6M Buy
+211,935
New +$20.8M 0.24% 139

Other funds holding EHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Freestone Grove Partners's EHC Position: Q1 2026 in Review

Freestone Grove Partners increased its Encompass Health (EHC) stake by 1,967% in Q1 2026, buying an estimated $23.2M and bringing the position to 237,626 shares worth $23M. The position accounts for 0.16% of the portfolio, ranked #195.

Freestone Grove Partners first reported a position in EHC in Q4 2024 and has held it in 6 quarters since. The position peaked at $46M in Q3 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Freestone Grove Partners held 237,626 shares of Encompass Health worth $23M as of Q1 2026.
  • Freestone Grove Partners bought 226,130 Encompass Health shares in Q1 2026, an estimated $23.2M.
  • Encompass Health made up 0.16% of Freestone Grove Partners's portfolio in Q1 2026, its #195 holding.
  • Freestone Grove Partners first reported a position in Encompass Health in Q4 2024 and has held it in 6 quarters since.
  • Freestone Grove Partners's Encompass Health position peaked at $46M in Q3 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.